CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 411 enrolled
Drug / intervention
3804-250A +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00762476
NCT00762476Phase 2Completed
CompareCT.gov

A MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II EFFICACY TRIAL OF AV LOTION (FORMULA NO. 3804-250A) FOR THE PREVENTION OF COLD ILLNESS IN HUMAN SUBJECTS

The Dial Corporation·interventional·Posted Sep 30, 2008·Updated Apr 16, 2012

In Brief

A Phase 2 clinical trial evaluating 3804-250A and 3804-291 for Common Cold. Completed, enrolled 411 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the efficacy of 3804-250A in the prevention of the common cold. The study will also evaluate whether 3804-250A prevents rhinovirus infection, a virus that causes many common colds.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Cold
CountriesUnited States
CollaboratorsHill Top Research, TKL Research, Inc.

Timeline

Phase 2CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 30, 2008
Enrollment StartAug 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 17.8 years ago

Interventions

3804-250Adrug

* topical product * apply 2 pumps * apply at least every 4 hours or after hand washing

3804-291drug

* topical * apply 2 pumps * apply at least every 4 hours or after hand washing